Mesothelioma Specialists
A specialist who routinely cares for mesothelioma patients is aware of what to look out for on imaging tests, bloodwork and other diagnostic tools. Mesothelioma doctors may also offer advanced treatments that improve prognoses.
When choosing a mesothelioma specialist take into consideration the hospital affiliation, experience and availability. Patients should be relaxed and well-supported throughout their visit.
Raja Flores
Dr. Raja Flores, a mesothelioma expert with a high reputation for his surgical and patient care abilities is known for his expertise. He is currently the chief of the thoracic surgery department at Mount Sinai Medical Center in New York City.
Flores gained expertise in treating lung cancer and mesothelioma during his time at Brigham and Women's Hospital. mesothelioma settlement received training from renowned mesothelioma specialist Dr. David Sugarbaker. He is an expert in treating lung cancer, pleural tumors and esophageal cancer.
He helped pioneer the lung-sparing pleurectomy/decortication surgery that has been successfully used as a curative procedure in scores of mesothelioma cases. He also played a key role in the creation of the video-assisted surgery thoracic (VATS) the lobectomy, which is now considered to be the most effective treatment for lung cancer. This minimally-invasive procedure requires only three small incisions for the removal of diseased lung sections.
In his mesothelioma-related career, Flores has published more than 100 peer-reviewed papers and book chapters. He has received many professional awards, including being recognized as a New York Top Doctor and America Top Doctor. He has also participated to numerous clinical research studies. One of these focused on the efficacy of treatment of mesothelioma using neoadjuvants.
Mesothelioma can be diagnosed by physical examination, blood tests and imaging. Patients may not show symptoms until the disease has reached an advanced stage. When this occurs it is possible that they will experience pain in the throat, abdomen or chest as well as fatigue, coughing, and difficulty breathing. A doctor can remove the excess fluid to look for cancerous cells and determine if a patient has mesothelioma that is mixed or epitheliod.
Asbestos is the primary reason for mesothelioma. Anyone who has been exposed to asbestos during construction, maintenance and repair of power plants, ships or factories are at greater risk of developing the cancer.
Multidisciplinary teams can offer the best treatment for mesothelioma. In addition to the surgeon, patients should seek out radiation specialists and medical oncologists who specialize in mesothelioma therapy. These specialists can devise plans to treat the cancer with chemotherapy and/or radiation. Patients with mesothelioma should also ask their doctors about the number of mesothelioma cases they have dealt with.
Robert Cameron
Robert Cameron, a renowned mesothelioma expert graduated from UCLA's medical school nearly 30 years ago. He completed his surgical residency at Cornell University Medical Center and the National Cancer Institute before starting his mesothelioma specialization. mesothelioma law firm with mesothelioma benefit from his expertise in lung-sparing surgeries and minimally invasive procedures such as thorascopic surgeries. Cameron is a mesothelioma expert and has published over 35 papers on thoracic and oncology.
He is the co-founder of the Mesothelioma Applied Research Foundation and is the scientific advisor for the Pacific Mesothelioma Center. He is also the chief of thoracic surgery for both the University of California Los Angeles and West Los Angeles Veterans Affairs Medical Center mesothelioma centers.
Dr. Cameron is a leader in mesothelioma treatment and has helped thousands of asbestos victims. He is committed to improving the quality and access of mesothelioma treatment to patients. He is also an active advocate for patients and their family members throughout the treatment process.
As a mesothelioma specialist, Cameron has expertise in treating both mesothelioma that is peritoneal and pleural. He is trained in a variety of surgical mesothelioma treatments including cytoreductive surgery, hyperthermic intraperitoneal chemotherapy and pleurectomy with decortication. He is also skilled in pericardial mesothelioma treatment which involves the removal of tumors from lining of the heart and the surrounding tissues.
It is essential to choose a mesothelioma doctor who is a member of an institution for cancer that you trust. A top specialist has the staff, equipment and clinical trials to provide the treatment you require. Also, it is essential to bring any relevant work history records and scans of your imaging to your appointment. It is also possible to bring a family member or friend along with you for support and to help you remember important information during your appointment.
If you are not interested in surgery or unable to undergo it, there are alternative options for mesothelioma treatments like immunotherapy and radiation. Many mesothelioma specialists are skilled in coordinating these other treatment options that include surgery. The mesothelioma experts at your chosen cancer center can help you make these decisions during your mesothelioma diagnosis.
Raphael Bueno
Bueno is a specialist in the treatment of thoracic tumors, including mesothelioma. He is currently working to improve the way mesothelioma and other lung cancers are prevented and treated. Bueno's research is helping doctors understand mesothelioma on the molecular level. mesothelioma law firm will aid mesothelioma to be diagnosed, and could lead to new ways of treatment.
As the Chief of Thoracic Surgery and Vice-Chair of Surgery for Cancer Research at Brigham and Women's Hospital, Raphael Bueno is committed to maintaining the institution's world-leading position in mesothelioma research and treatment. Bueno is the director of the hospital’s International Mesothelioma Program. He has a wide range of expertise related to mesothelioma treatment, diagnosis and prevention.
Although leadership, patient care, and teaching were all crucial aspects of his professional career but his time at BWH has been focused on research. He has developed tests to aid surgeons in identifying mesothelioma tumors during a surgical biopsy, and he is working on methods to make the procedure less invasive. He is also studying mesothelioma's gender-specific characteristics, and how tumors develop.
Bueno began his career at BWH as a surgical student after he graduated from Harvard Medical School. He worked alongside mesothelioma pioneer Dr. David Sugarbaker, and he learned a lot about mesothelioma through his mentor. After his internship he completed an oto-cardiothoracic surgical residency at Massachusetts General Hospital. He then returned to BWH and set up a private surgery practice and a laboratory for mesothelioma.
Among his most significant achievements is developing iVats, which allows surgeons to pinpoint mesothelioma tumors and remove them during an extrapleural pneumonectomy. This technique is a significant improvement on the traditional method that is often ineffective and requires more tissue to be removed than is necessary. The new technique has also improved the outcomes for patients suffering from mesothelioma.
Bueno is involved in numerous clinical trials to create innovative methods of mesothelioma detection and treatment. He is a member of the Dana-Farber Cancer Institute and has appointments at Brigham and Women's Faulkner Hospital and Carney Hospital. He is also a fellow of the American College of Chest Physicians.
Paul Sugarbaker
Paul Sugarbaker is a nationally recognized mesothelioma specialist. He is well-known for his work in mesothelioma peritoneal and abdominal cancers. His innovative method of treating this rare cancer and pushing the boundaries of treatment helped increase survival rates. He developed, refined and popularized a technique that combined chemotherapy with cancer surgery to treat peritoneal msothelioma. This procedure is now referred to as the Sugarbaker Method. He continues to travel the world to train young surgeons on this groundbreaking procedure.
A mesothelioma specialist has many years of experience treating asbestos-related diseases. They are also familiar with the most current mesothelioma treatment options and clinical trials. Mesothelioma patients must be prepared for their first meeting with a mesothelioma specialist by bringing their medical records, a list with questions and a willingness to communicate.
There are a variety of mesothelioma specialists, and each mesothelioma specialist will have their own area of expertise. There are thoracic and general surgeons as well as pulmonologists. Pathologists, radiation oncologists, and radiation oncologists. Each mesothelioma specialist play a vital role in the care of patients.
A thoracic surgeon treats tumors and other problems in the chest cavity, for example mesothelioma pleural. They may also perform lung surgery to reduce tumors and improve breathing abilities. They can prescribe medications to improve symptoms or extend life time.
A thoracic surgeon can assist patients with the most challenging treatment options. They can also aid patients in locating mesothelioma associations and other sources.
Paul Sugarbaker earned his undergraduate degree at Wheaton College, located in Illinois. He was a student at Cornell University Medical College in New York City before completing his residency in surgery at Peter Bent Brigham Hospital in Boston which is which is a Harvard University affiliated program. Then he relocated to Atlanta, Georgia, where he worked for Emory University in Atlanta for two years before returning to Washington, D.C.
Paul Sugarbaker is an internationally renowned cancer specialist and surgeon. He has been ranked as one of America's Top Doctors, and he is a part of a variety of professional associations. He is best known for his relentless pursuit of the cure for mesothelioma peritoneal, which led to the HIPEC procedure (heated intraperitoneal chemotherapy) that has been proved to prolong the lives of patients suffering from this rare cancer.